PHT's eDiary System Selected by Agile Therapeutics for Phase III Trial

PHT Corporation, a provider of technologies used to collect patient-driven eData for clinical research, says that its LogPad® System has been selected by Agile Therapeutics for use in its SECURE Phase III trial for its investigational product candidate, Twirla®. Agile's Senior VP of Clinical Development noted it chose the LogPad System for its proven track record of data quality and security, and comfort and convenience for patients, as well as PHT's leadership, experience and excellent customer service.

Read the full release here.